Larimar Therapeutics, Inc.
Q2 2018 13F Holders
Symbol
LRMR
CUSIP
98885E103
Type
Equity
Class
COM
Num filings
91
Total reported value, excl. options
$261 M
Compare 2018 Q2 to
2020 Q1
2019 Q4
2019 Q3
2019 Q2
2019 Q1
2018 Q4
2018 Q3
2018 Q1
2017 Q4
2017 Q3
2017 Q2
2017 Q1
2016 Q4
2016 Q3
2016 Q2
2016 Q1
2015 Q4
2015 Q3
2015 Q2
2015 Q1
2014 Q4
2014 Q3
2014 Q2
Manager
Report Date
Value ($000)
Shares
Option Type